CytoMed Therapeutics Limited Postemployment Benefit Expense Defined Contribution Plans
CytoMed Therapeutics Limited (GDTC) reported Postemployment Benefit Expense Defined Contribution Plans of SGD 172.62 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans · last filed 2026-03-31
| Period end | Postemployment Benefit Expense Defined Contribution Plans 12 month |
|---|---|
| 2025-12-31 | 172.62K SGD 20-F · filed 2026-03-31 |
| 2024-12-31 | 141.29K SGD 20-F · filed 2026-03-31 |
| 2023-12-31 | 117.28K SGD 20-F · filed 2026-03-31 |
| 2022-12-31 | 80.21K SGD 20-F · filed 2025-04-28 |
| 2021-12-31 | 66.79K SGD 20-F · filed 2024-04-22 |
| 2020-12-31 | 55.13K SGD 20-F · filed 2023-05-01 |